Jove
Visualize
Contact Us

Related Experiment Videos

[Multiple sclerosis in Mexico: a multicentre study].

M Velázquez-Quintana1, M A Macías-Islas, V Rivera-Olmos

  • 1Hospital Regional # 1 IMSS. Chihuahua, México.

Revista De Neurologia
|June 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polymorphisms CYP2R1 rs10766197 and CYP27B1 rs10877012 in Multiple Sclerosis: A Case-Control Study.

Journal of immunology research·2022
Same author

Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson's disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2020
Same author

MIF functional polymorphisms (-794 CATT<sub>5-8</sub> and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.

Journal of neuroimmunology·2018
Same author

Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.

Immunogenetics·2018
Same author

Effect of melatonin administration on cyclooxygenase-2 activity, serum levels of nitric oxide metabolites, lipoperoxides and glutathione peroxidase activity in patients with Parkinson’s disease

Gaceta medica de Mexico·2017
Same author

Efficacy of fish oil on serum of TNF α , IL-1 β , and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b.

Oxidative medicine and cellular longevity·2013
Same journal

The Correlation Between and Variability of Three Balance Scales in the Assessment of Balance Function in Patients With Ataxia.

Revista de neurologia·2026
Same journal

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Revista de neurologia·2026
Same journal

Mapping the Evidence: Central Sleep Apnea Syndromes During Sleep and Stroke-A Scoping Review.

Revista de neurologia·2026
Same journal

Developmental and Epileptic Encephalopathy Due to a Novel <i>ARHGEF9</i> Deletion Variant: Case Series of Two Siblings.

Revista de neurologia·2026
Same journal

P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.

Revista de neurologia·2026
Same journal

[Effectiveness and Risk of Recurrence of Pulsed Radiofrequency in Trigeminal Neuralgia and Chronic Cluster Headache].

Revista de neurologia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

This multicenter study in Mexico characterized multiple sclerosis (MS) using validated tools. The clinical profile of MS in Mexico aligns with international findings, despite low prevalence.

Area of Science:

  • Neurology
  • Epidemiology
  • Public Health

Context:

  • Multiple sclerosis (MS) in Mexico has been poorly understood due to limited, regional studies with varied methodologies.
  • Previous research focused on small, geographically restricted populations, hindering a national understanding of MS.
  • A need existed for a comprehensive, Mexico-wide study using standardized criteria to define MS characteristics.

Purpose:

  • To define the clinical profile and sociodemographic aspects of multiple sclerosis (MS) in Mexico.
  • To establish a national understanding of MS using validated, homogeneous criteria and tools.
  • To provide a representative overview of MS patients across Mexico's major regions.

Summary:

  • A multicenter study surveyed 337 patients across Mexico's five most populated regions using a validated 142-question survey.

Related Experiment Videos

  • Patients were clinically diagnosed with MS using Schumaher and Poser criteria.
  • The study found MS predominantly affected mestizo individuals (99.1%), with an average age of 37.9 years, and a higher prevalence in females (69.7%).

    • Impact:

    • This study provides the first representative, multicenter data on multiple sclerosis (MS) in Mexico.
    • Findings indicate the clinical profile of MS in Mexico is consistent with international patterns, suggesting similar etiological factors.
    • The research establishes a crucial baseline for future epidemiological studies and healthcare planning for MS in Mexico.